Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC728241 Inhibitors

Staurosporine, renowned for its prowess as a kinase inhibitor, casts a wide net, potentially curtailing the activity of a vast array of kinases. This broad-spectrum action places it as a prime candidate for influencing LOC728241, assuming it's part of the kinase ensemble. Rapamycin, on the other hand, is a specialist in immunosuppression that targets mTOR by forming a complex with FKBP12. If LOC728241 is intertwined with the mTOR pathway, rapamycin could significantly alter its operational landscape. LY294002, with its selective inhibition of PI3K, serves to dampen Akt signaling pathways, which, if associated with LOC728241's functionality, might suppress its activity. Similarly, PD98059 takes aim at MEK to block the MAPK/ERK pathway, potentially reshaping LOC728241's role if it's a component of this signaling cascade. U0126, another MEK adversary, also impedes MAPK/ERK activation, hinting at a possible pivot in LOC728241's function contingent on this pathway.

SB203580 targets p38 MAPK and could modify LOC728241 activity if it is reactive to cellular stress signals, while SP600125, a JNK inhibitor, may influence LOC728241 if JNK signaling forms part of its regulatory network. Bortezomib throws a wrench into the proteasomal machinery, disrupting protein degradation. If LOC728241's stability is maintained by ubiquitination, its levels could be bolstered by this intervention. Delving into protein stabilization, 17-AAG (Tanespimycin) challenges Hsp90, which might impact LOC728241 if it relies on Hsp90's chaperoning for its stability or function. Thapsigargin, a disruptor of calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase, could affect LOC728241 if it is calcium-dependent, altering its functional repertoire. Cyclopamine puts the brakes on the Hedgehog pathway, potentially altering LOC728241 activity if the protein is an actor within this signaling troupe. Lastly, Imatinib, by targeting specific tyrosine kinases such as BCR-ABL, c-Kit, and PDGFR, might alter the phosphorylation status and consequently the activity of LOC728241, should it be influenced by these kinases.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor that can inhibit a broad range of kinases, potentially affecting LOC728241 if it is kinase-associated.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

A Hedgehog signaling pathway inhibitor that can alter cell signaling, potentially affecting LOC728241 if part of this pathway.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that can disrupt protein degradation pathways, potentially affecting LOC728241 if it is degradation-linked.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

An ER stress inducer that inhibits the Ca2+ ATPase, potentially affecting LOC728241 if it is involved in calcium homeostasis.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

A MEK inhibitor that can inhibit the MAPK/ERK pathway, potentially affecting LOC728241 if it interacts with this pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that can suppress the AKT pathway, potentially affecting LOC728241 if it is associated with this pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

A MAPK inhibitor that can prevent the activation of MAPK/ERK, potentially affecting LOC728241 if it is part of this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that can alter cell growth and survival signals, potentially affecting LOC728241 if involved in these processes.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

A tyrosine kinase inhibitor that can inhibit BCR-ABL and other kinases, potentially affecting LOC728241 if it is kinase-related.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$66.00
$153.00
16
(2)

An Hsp90 inhibitor that can disrupt client protein stabilization, potentially affecting LOC728241 if it is an Hsp90 client.